EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 56% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this video, recently appointed CEO Andy Thorburn reviews the company’s H117 results, including a discussion of the performance at a divisional level. He describes progress to date with the reorganisation plan and outlines what is left to do in the second half. He provides an update on the company’s plans to develop the Patient online healthcare information business. Finally, he discusses the current trading environment and gives his views on the company’s short and long-term outlook.